Rockefeller Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$44.4M Buy
99,738
+8,774
+10% +$3.91M 0.1% 203
2025
Q1
$44.1M Sell
90,964
-7,825
-8% -$3.79M 0.11% 186
2024
Q4
$39.8M Buy
98,789
+28,240
+40% +$11.4M 0.1% 195
2024
Q3
$32.8M Sell
70,549
-612
-0.9% -$285K 0.09% 230
2024
Q2
$33.4M Buy
71,161
+1,280
+2% +$600K 0.09% 202
2024
Q1
$29.2M Buy
69,881
+9,356
+15% +$3.91M 0.09% 237
2023
Q4
$24.6M Buy
60,525
+7,635
+14% +$3.11M 0.08% 249
2023
Q3
$18.4M Buy
52,890
+1,467
+3% +$510K 0.07% 278
2023
Q2
$18.1M Buy
51,423
+5,695
+12% +$2M 0.07% 292
2023
Q1
$14.4M Sell
45,728
-1,816
-4% -$572K 0.06% 337
2022
Q4
$13.7M Sell
47,544
-241
-0.5% -$69.6K 0.07% 301
2022
Q3
$13.8M Buy
47,785
+4,818
+11% +$1.39M 0.07% 284
2022
Q2
$12.1M Buy
42,967
+6,039
+16% +$1.7M 0.06% 301
2022
Q1
$9.64M Buy
36,928
+6,807
+23% +$1.78M 0.05% 380
2021
Q4
$6.61M Buy
30,121
+6,248
+26% +$1.37M 0.03% 467
2021
Q3
$4.33M Buy
23,873
+6,477
+37% +$1.17M 0.02% 510
2021
Q2
$3.51M Sell
17,396
-1,346
-7% -$271K 0.02% 550
2021
Q1
$4.03M Buy
18,742
+7,191
+62% +$1.55M 0.03% 409
2020
Q4
$2.73M Buy
11,551
+599
+5% +$141K 0.02% 444
2020
Q3
$2.98M Buy
10,952
+452
+4% +$123K 0.03% 346
2020
Q2
$3.05M Buy
10,500
+2,282
+28% +$662K 0.03% 314
2020
Q1
$1.96M Buy
8,218
+5,987
+268% +$1.42M 0.03% 342
2019
Q4
$488K Buy
2,231
+210
+10% +$45.9K 0.01% 589
2019
Q3
$342K Buy
2,021
+525
+35% +$88.8K ﹤0.01% 532
2019
Q2
$274K Sell
1,496
-1,208
-45% -$221K ﹤0.01% 533
2019
Q1
$497K Buy
2,704
+2,122
+365% +$390K 0.01% 475
2018
Q4
$96K Buy
582
+532
+1,064% +$87.8K ﹤0.01% 460
2018
Q3
$10K Hold
50
﹤0.01% 587
2018
Q2
$8K Buy
+50
New +$8K ﹤0.01% 655